DRUG · Unmapped registry intervention
Sulphadoxine-pyrimethamine
Find medicine records ·
Find other trials using this name
Clinical trial
Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
NCT00811421
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Mefloquine (full dose)
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Mefloquine (split dose)
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
mefloquine
Normalized identity: mefloquineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
placeboDRUG
mefloquineDRUG · verified · RxNorm: mefloquine
Sponsors & collaborators
Hospital Clinic of Barcelonalead sponsor
Institut de Recherche pour le Developpementcollaborator
Université d'Abomey-Calavicollaborator
Albert Schweitzer Hospitalcollaborator
Kenya Medical Research Institutecollaborator
Ifakara Health Institutecollaborator
Centro de Investigacao em Saude de Manhicacollaborator
Centers for Disease Control and Preventioncollaborator
Malaria in Pregnancy Consortiumcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00811421 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.